Red Cedar Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Red Cedar Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.7M	Buy	186,501 +306	+0.2%	+$2.67K	1.08%	24
2022 Q3	$1.5M	Sell	186,195 -8	-0%	-$71	1.04%	28
2022 Q2	$1.4M	Buy	186,203 +164	+0.1%	+$1.43K	0.95%	30
2022 Q1	$1.75M	Buy	186,039 +119	+0.1%	+$993	1.05%	26
2021 Q4	$1.49M	Buy	185,920 +1,250	+0.7%	+$11.3K	0.85%	31
2021 Q3	$1.8M	Buy	184,670 +2,068	+1%	+$19.4K	1.1%	25
2021 Q2	$1.81M	Sell	182,602 -527	-0.3%	-$5.58K	1.14%	24
2021 Q1	$2.11M	Buy	183,129 +1,821	+1%	+$20.9K	1.41%	21
2020 Q4	$1.75M	Buy	181,308 +67,228	+59%	+$644K	1.28%	23
2020 Q3	$1.03M	Buy	114,080 +536	+0.5%	+$5.67K	0.9%	31
2020 Q2	$1.4M	Sell	113,544 -1,629	-1%	-$18.4K	1.27%	24
2020 Q1	$1.03M	Buy	115,173 +68,176	+145%	+$698K	1.04%	28
2019 Q4	$461K	Buy	46,997 +584	+1%	+$5.21K	0.35%	48
2019 Q3	$319K	Hold	46,413	–	–	0.26%	50
2019 Q2	$428K	Sell	46,413 -254	-0.5%	-$3.06K	0.36%	43
2019 Q1	$732K	Buy	46,667 +380	+0.8%	+$6.7K	0.62%	34
2018 Q4	$714K	Buy	46,287 +40,436	+691%	+$829K	0.69%	31
2018 Q3	$126K	Hold	5,851	–	–	0.11%	69
2018 Q2	$142K	Hold	5,851	–	–	0.13%	68
2018 Q1	$99K	Hold	5,851	–	–	0.09%	73
2017 Q4	$111K	Buy	+5,851	New	+$88K	0.09%	71

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Red Cedar Capital's TEVA Position: Q4 2022 in Review

Red Cedar Capital increased its Teva Pharmaceuticals (TEVA) stake by 0.16% in Q4 2022, buying an estimated $2.67K and bringing the position to 186,501 shares worth $1.7M. The position accounts for 1.08% of the portfolio, ranked #24.

Red Cedar Capital first reported a position in TEVA in Q4 2017 and has held it in 21 quarters since. The position peaked at $2.11M in Q1 2021. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

Red Cedar Capital held 186,501 shares of Teva Pharmaceuticals worth $1.7M as of Q4 2022.
Red Cedar Capital bought 306 Teva Pharmaceuticals shares in Q4 2022, an estimated $2.67K.
Teva Pharmaceuticals made up 1.08% of Red Cedar Capital's portfolio in Q4 2022, its #24 holding.
Red Cedar Capital first reported a position in Teva Pharmaceuticals in Q4 2017 and has held it in 21 quarters since.
Red Cedar Capital's Teva Pharmaceuticals position peaked at $2.11M in Q1 2021.
422 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Red Cedar Capital's 13F filing for Q4 2022, filed 6 Feb 2023.